chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Cancer (unknown cancer type/unknown cancer start date); This spontaneous case was reported by a pharmacist and describes the occurrence of NEOPLASM MALIGNANT (Cancer (unknown cancer type/unknown cancer start date)) in an 80-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038B21A and 046A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 17-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On an unknown date, the patient experienced NEOPLASM MALIGNANT (Cancer (unknown cancer type/unknown cancer start date)) (seriousness criterion medically significant). The patient was treated with Radiotherapy (chemotherapy and radiation treatment) for Neoplasm malignant. At the time of the report, NEOPLASM MALIGNANT (Cancer (unknown cancer type/unknown cancer start date)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported. The pharmacist also reported that, 2 months ago the patient was eating something and it cut her esophagus causing bleeding. The patient required a blood transfusion.  Treatment reported for Cancer included chemotherapy and radiation treatment approximately 2 months ago.  This is a spontaneous case concerning an 80-year-old female patient with no medical history reported, who experienced the unexpected event of neoplasm malignant. The event occurred on an unknown date, while the second dose of mRNA  1273 vaccine was received on 17-Apr-2021. Neoplasm malignant a medically significant event, outcome of which was still unknown at the time of report. Patient was having chemotherapy and radiation treatment for approximately 2 months. The reporter's assessment was not provided. The benefit-risk relationship of the vaccine is not affected by this report.; Sender's Comments: This is a spontaneous case concerning an 80-year-old female patient with no medical history reported, who experienced the unexpected event of neoplasm malignant. The event occurred on an unknown date, while the second dose of mRNA  1273 vaccine was received on 17-Apr-2021. Neoplasm malignant a medically significant event, outcome of which was still unknown at the time of report. Patient was having chemotherapy and radiation treatment for approximately 2 months. The reporter's assessment was not provided. The benefit-risk relationship of the vaccine is not affected by this report.
This spontaneous report as received from a Healthcare Student refers to a patient of unknown age. On an unknown date the patient was vaccinated SC in the left deltoid with a 0.65 ml dose of ZOSTAVAX (start date and indication not reported). On an unknown date the patient experienced a sensation of burning on the left side of the body within three minutes of receiving ZOSTAVAX in the left deltoid, and the patient did progress to develop vesicles on the left-side of the face and body. The healthcare student reported that she had already reported this AE to VAERS, and she stated that since this AE occurred "a while ago", the vesicles have already resolved. Varicella Zoster Virus Identification Program (VZIP) discussed, but since the patient's vesicles have healed, the healthcare student declined the packet. No PQC identified. Then is was clarified that the vesicles developed "within 3-5 days" of the receipt of the dose of ZOSTAVAX. On an unspecified date, the patient recovered from the events.  Additional information has been requested.
Erythema, edema started at injection site (R) deltoid. Day 2-3 erythema moved distally toward elbow, no longer affecting injection site.
cried hard cont x 1 1/2 hr; vomited x 2; swelling of lt leg w/reddness greater then softball; pt to soak in warm tub use tylenol supp;
Red warm area to LEFT arm at site of VARICELLA injection. Area sore to the touch. Mom took her to see MD. No treatment given per MD. Mom states the area was clear by the am 8/29/2014.
1/11/2021 | 7 days after -Itchy at injection site but not red or swollen  1/12/2021 | 8 days after -Itchy at injection site -Red at injection site -Hot at injection site -Swollen at injection site -Right Arm Weakness -Feeling of random electrical impulses  ER Visit on 1/12/2021 -Ultrasound completed, no abscess seen -advised to take benadryl to relieve itchiness -advised to take acetaminophen & Ibuprofen for pain -Alternate use of hot & cold pack  for swolleness  1/13/2021, 9 Days after -Right Arm Pain -Redness Traveling 1/4 of an inch outside of circle from 1/12/2021 -Swollen by injection site -Red at Injection Site -Hot At Injection site -Feeling of fatigue -Headache
Pain during injection. By evening pain increased, couldn't sleep. Next day couldn't lift my arm at all. Four days until I could get a jacket on without struggling. Day seven better but range of motion still not as it was before vaccine. Didn't have any problem with the first vaccine in the series.
Erythema and induration 11 cm x 9 cm Lt thigh area.
This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. The patient's medical history, concurrent conditions, drug reactions/allergies and concomitant medications were not reported. On 01-NOV-2016, the patient was vaccinated with an improperly stored dose of PEDVAXHIB lot # L042835, expiration date:19-AUG-2018, as prophylaxis (Strength and dose were not reported), which experienced a temperature excursion between 46 and 77 Fahrenheit degrees for 2 hours and 30 minutes. There was no previous temperature excursions reported. Digital data logger was involved. No adverse effects were reported. A product quality complaint was not involved. This is one of several reports received from the same reporter. Additional information has been requested. Sender's Comments: US-009507513-1702USA000452: US-009507513-1702USA003693: US-009507513-1702USA003694: US-009507513-1702USA003695: US-009507513-1702USA003696: US-009507513-1702USA003697.
Dizziness, Headache, CoughWheeze, Nausea Vomiting, HYPERglycemia,  site pain, red, swelling fatigue  Narrative:
Caught covid, asymptomatic,     I received a call from my brother that he had it and I needed to get tested.   All I felt was a little tired and a runny nose with a 102 fever. I did not know it was covid until I was tested. I Treated with cold medicine and Tylenol to clear up runny nose and reduce the fever. Symptoms went away with in a week. I went an was tested after my symptoms cleared up, I had no fever and felt fine at the time of the test. Symptoms had been gone for 3 days before test.
Chills, aches, fever 100.2 for 16 hours began morning after vaccine
swollen lips and tongue, redness on tongue and inside of lips.; swollen lips and tongue, redness on tongue and inside of lips.; swollen lips and tongue, redness on tongue and inside of lips.; swollen lips and tongue, redness on tongue and inside of lips.; This is a spontaneous report from a contactable nurse. A female patient of an unspecified age received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiry date were not reported), via an unspecified route of administration on 05Jan2021 at a single dose for COVID-19 immunization. Medical history included hypertension (HTN), hyperlipidaemia (HLD) and arthritis from. The patient's concomitant medications included adalimumab (HUMIRA).  The patient received her first dose of Pfizer Biontech Covid 19 vaccine on05Jan2021. She began feeling symptoms on 06Jan2021. She reported the following: swollen lips and tongue, redness on tongue and inside of lips. On 07Jan2021, the symptoms persisted, and the patient took Benadryl and Claritin. Her symptoms were still present at the time of report. She would like to know if she should get the second dose. And if there was any literature available for patients who take Humira and receive the vaccine.   Information on the lot/batch number has been requested.
vaccine was expired, no temperature excursion occurred and Moderna determined the vial "maintained the activity necessary to  protect against the SARS CoV-2 virus at the time of administration".  Patient reported no adverse reactions.
Acute urticarial reaction 15 minutes after administration of MMR and DTaP. No irregular respiration dizziness Given Benadryl and subcutaneous epinephrine.
Day #1 - 430 - 500 PM - Left hip & knee pain sudden nausea muscle & bone pain weakness body aches 9/24/10 severe chills - uncontrollable shaking no appetite fever headache dizzy. Day #1 9/24/10 To bed with help (severe joint pain) heat pads to treat chills eyes - v. red, burning exhausted - sleep intermittently 14 hrs. v. dizzy throughout night. Day #2 9/25/10 waken with headache dizziness itchy body nose/throat irritation ("sore") red arm - no swelling diarrhea later - 11 AM. Day #3 9/26/10 headache - rt. ear & head pain (rt. side) - sinus ? irritation. Day #4 9/27/10, feeling better - weak but more ok. Note: An unpleasant illness for 4 days - "as if I had the flu" - a very bad flu!".
Patient seen in office 1/25/17. Presented with (L) arm redness and some swelling around injection site. Otherwise patient looked well.
Fetal Demise. I was pregnant with a boy and my due date was on 9/11/2021. This was my first pregnancy. The pregnancy went really smooth with no complications. Genetic screening came back showing low risk. Ultrasound 2 days prior to the vaccine (3/30) shown normal development and fetus was on track for being 16 weeks. Vaccine was received on 4/1. No weight gain or fetal movement was observed in April. No heartbeat was found during ultrasound on 4/28. Measurement of fetus equals to 16/17 week. Ob believe heartbeat stopped within a week after appointment on 3/30. I had an induced labor as a result of fetal demise on 4/30. Baby's cord was not tied as observed in delivery. No visible birth defect was observed either.
cold; Runny nose; Sneezing; loss of sense of smell; Loss of taste; symptoms of flu; Chills; A little fever; A little body aching; This spontaneous case was reported by a patient and describes the occurrence of CHILLS (Chills), PYREXIA (A little fever), MYALGIA (A little body aching), NASOPHARYNGITIS (cold) and RHINORRHOEA (Runny nose) in a 42-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 036C21A and 016C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 04-Jun-2021, the patient experienced CHILLS (Chills), PYREXIA (A little fever) and MYALGIA (A little body aching). On 06-Jun-2021, the patient experienced NASOPHARYNGITIS (cold), RHINORRHOEA (Runny nose), SNEEZING (Sneezing), ANOSMIA (loss of sense of smell), AGEUSIA (Loss of taste) and INFLUENZA LIKE ILLNESS (symptoms of flu). On 04-Jun-2021, PYREXIA (A little fever) had resolved. At the time of the report, CHILLS (Chills), MYALGIA (A little body aching), NASOPHARYNGITIS (cold), RHINORRHOEA (Runny nose), SNEEZING (Sneezing), ANOSMIA (loss of sense of smell), AGEUSIA (Loss of taste) and INFLUENZA LIKE ILLNESS (symptoms of flu) outcome was unknown.            Concomitant product use was not provided by the reporter.   No treatment information was provided.
pt recvd vax; devel large hematoma and compartment syndrome in rt arm; pt was hospitalized; pt was later found to have idosynocrati factor VIII dec.
Patient complains of shortness of breath, very sore arm, inflamed lymph node under left arm, chills, fever and heart arrhythmias, Patients states he was in perfect health before receiving the Moderna Vaccine.  He refuses to go to a doctor for evaluation. The request that I complete VAERS
Other than normal body aches and pains, but the next day was high as a kite; Other than normal body aches and pains; Clearned up her runny nose and sinus problem; Clearned up her runny nose and sinus problem; This is a spontaneous report from a contactable other health care professional (Nurse). A 92-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot number and expiration date was not reported), via an unspecified route of administration on 23Jan2021 as dose1, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On an unspecified date the patient experienced other than normal body aches and pains, but the next day was high as a kite followed by cleaned up her runny nose and sinus problem. It was reported that patient(her friend) got high after the vaccine and didn't want to talk to anybody, stated it was her first dose. Stated her friend is going to be 93 in March, exact date of birth is unknown, stated with the first vaccine her friend said she felt no other symptoms except it cleared up her runny nose and sinus problem she had, no more than the normal pains that she had. The outcome of the events was unknown.  Information on the lot/batch number has been requested. Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Pt received Pfizer x2. Admitted to the hospital on 8/12 for COVID. Being treated with remdesivir, tocilizumab and dexamethasone.
Hair loss; Dose number: 3; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program. The reporter is the patient.  A 74 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm right, administration date 21Aug2021 (Batch/Lot number: unknown) at the age of 74 years as dose 3 (booster), single for covid-19 immunisation. Relevant medical history included: "Small cell ovarian cancer" (unspecified if ongoing); "Thyroid" (unspecified if ongoing); "Latex Adhesive" (unspecified if ongoing); "Arthritis" (unspecified if ongoing). Concomitant medication(s) included: SYNTHROID; ZOLOFT; PRAVASTATIN; METOPROLOL; LISINOPRIL. Past drug history included: Effexor, reaction(s): "Known allergies: Effexor"; Lamotrigine, reaction(s): "Known allergies: lamotrigine". Vaccination history included: Bnt162b2 (Brand: Pfizer, Dose Number: 1, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: 22Jan2021, when the patient was 73 years old, for Covid-19 immunization; Bnt162b2 (Brand: Pfizer, Dose Number: 2, Batch/Lot No: Unknown. Unable to locate or read the details, Location of injection: Arm Left), administration date: 23Feb2021, when the patient was 73 years old, for COVID-19 immunization. The following information was reported: IMMUNISATION (non-serious) with onset 21Aug2021, outcome "unknown", described as "Dose number: 3"; ALOPECIA (non-serious) with onset 01Dec2021, outcome "not recovered", described as "Hair loss". The event "hair loss" was evaluated at the physician office visit. Relevant laboratory tests and procedures are available in the appropriate section. Therapeutic measures were not taken as a result of alopecia.  Additional information: Reported event as per patient dermatologist thinks that patient loss of hair over the last few months is from the booster patient received the end of Aug. The patient had not received AE treatment, other vaccine in fourweeks and covid prior vaccination. The patient was covid tested post vaccination.  The lot number for bnt162b2 was not provided and will be requested during follow up.
Patient is fully vaccinated. COVID + 1/21/2022 on admission to hospital. 64-year-old female with metastatic colon cancer who presented to the hospital with declining functional status as well as altered mentation.  Patient is very lethargic and unable to take anything per oral. Admission dx: abdominal pain, thrombocytopenia, pleural effusion, metastic malignant neoplasm, anemia, edema.  Positive D-dimer.  on Eliquis. Acute kidney injury.  IV hydration given. Lacti acisosis.  Decadron. acute anemia (Hg 6.8).  1 unit PRBC given. PLTs 12. Severe sepsis. Patient will continue on broad-spectrum IV antibiotics with Cefepime. Comfort measures:  motphine drip, ativan.  Pt expired
Pain worsened; swelling of feet, legs, hands, arms and lips and is still ongoing; This is a spontaneous report from a contactable consumer 78-year-old female consumer (patient) reported for herself that: A 78-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 07Jul2021 10:00 (Batch/Lot Number: EW0161) as DOSE 1, SINGLE for Covid-19 immunisation. Medical history included cardiac failure congestive from 2004 and ongoing. The patient's Concomitant medications were not reported. The patient experienced Swelling of feet, legs, hands, arms and lips and is still ongoing on 09Jul2021, Pain worsened on an unspecified date. There was no Investigation Assessment. There was no Additional Vaccines Administered on Same Date of the Pfizer Suspect administration date of the suspect vaccine. AE(s) did not require a visit to Emergency Room and Physician Office Doctor came to her home. There was no Prior Vaccinations within 4 weeks. There was no AE(s) following prior vaccinations. Communication: Reference number provided. Caller initially said her first dose was on Thursday, then clarified it was on 07JUL 2021 when looking at vaccine card. Provided with phone number and hours of operation prior. The outcome of event was not recovered.
presented with bell's palsy (right sided facial paralysis) on January 10th which he reports had started about a week prior to his presenting to clinic.
mom states about 2-4hrs p/shots pt crying off & on all noc; pt did not sleep for most of noc; mom unsure of how high fever went 102.0R was highest noticed; taken to ER 48hrs p/shots; pt had viral infect
pt exp multiple s/sx p/rabies dose #2 including muscle twitching,cramping in muscles & joints;shooting pain & muscles & joints;rt hand heavy,achy & itchy;weak,tired all over;tingling & numbness in extremities;wakes up several times @ noc
sore arm; Hot flashes; This is a spontaneous report from a contactable consumer (Patient herself). A 65-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection and Lot Number: PAG780) via an unspecified route of administration in Left arm on 03Aug2021 as dose 1, single for COVID-19 immunisation. Patient medical history was reported as none. Concomitant medication included oxycodone taken for Medical Reasons. On 24Aug2021 patient experienced with sore arm and Hot flashes. Seriousness was reported as non-serious. Patient did not received any treatment for events. Outcome of events was recovering.
7/31/17 Pea size palpable lump under skin upper left thigh. Immunization administered 7/26/17. After administration red, purple rash surrounding injection site, resolved.
RN administered Epi pen at 1059 r/t PT demonstrating difficulty  swallowing/anaphylatic reaction. Rapid Response was called. PT stated he was  feeling better as demonstrated by breathing and swallowing without difficulty,  pulse WNL. PT was taken to the ED by RR Team for further assessment/observation.  Was DC'd from ED after reassured that was feeling fine.  Solumedrol adn benadryl given in ED.  DC'd with epipen, benadryl, prednisone, and famotidine.
Days 2 & 3 after vaccine: mild soreness in the injection (left) arm, mild headache Days 10- 12 after vaccine: hives & itchy red rash on shoulders and face; did not respond to Benadryl Days 13-18 hives & itchy red rash on shoulders and face; resolved with Prednisone* 4mg tabs in 6-day dose pak & daily Allegra 180mg Days 19-24 itchy ears and nose (from Prednisone) and itchy left shoulder; continued Allegra Day 25 resolved (* Methylprednisolone, Medrol Dose Pack3, 4mg tabs, daily 6 tabs then 5,4,3,2,1)
Headache; Body ache; Flu like symptoms; I was in the bed for like 2 days; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, lot number: EL9262), via an unspecified route of administration on 22Jan2021 at an unknown dose as a single dose for COVID-19 immunisation. The patient medical history was not reported. Concomitant medications included multivitamin and other unspecified medications. It was stated that the patient got the Pfizer vaccine exactly a week ago, the first dose and was wondering, I know it says the symptoms last for 48 hours but patient on 22Jan2021 had a headache and body ache still and patient was concerned if she should get the second vaccine because patient have flu like symptoms in 2021 and was in the bed for like 2 days and then it got better on an unknown date in 2021. The patient had Lab test few weeks ago included physical lab work with unknown results but that was before the vaccine that was the 8th of January. Therapeutic measures received for events headache, body ache and flu like symptoms included Tylenol, Ibuprofen. The outcome of events headache, pain was not recovered and outcome of other events was unknown.  Follow-up attempts are completed. No further information is expected.
Pt vaccinated with Influenza experienced weakness of the lower extremities with aching progressing to the trunk and upper extremities - GBS. Pt hospitalized transferred to EUH for plasma exchange.
She got the vaccine, and had a sore throat initially.  She felt in her mouth that it was swollen the first night.  Had a slight headache and a slight tiredness.  On Tuesday, the next day she felt unwell, but nothing abnormal about that.   That evening she had a fever, surprising to her as it was already the 2nd day.  The next day from there Wednesday, was weak, a little dizzy.  Then on Thursday she started feeling very very dizzy, she felt it coming on and about 10 minutes after she felt that she felt as is she was going to faint, very dizzy feeling.  She said it out loud so that somebody could recognize she was having problems.  She slumped into the chair with dizziness and not feeling well, a lot of weakness.   Since yesterday the sore throat has continued, and has had a cough since the beginning also.  She also had on Tuesday some diarrhea, but nothing too serious  Since yesterday she is still dizzy, has a canker sore, lips feel a little more puffy, still has headache.  She does not feel that she needs to go to the hospital, but still feeling unwell.  She also did have the arm pain at the injection site, and felt that she was getting better as her reaction didn't seem so severe and went away quickly.  She did not take anything for her symptoms.